title: Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer.
authors.affiliation: Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
authors.forename: Jie
authors.initials: J
authors.lastname: Wang
authors.forename: J Jack
authors.initials: JJ
authors.lastname: Lee
authors.forename: Luo
authors.initials: L
authors.lastname: Wang
authors.forename: Diane D
authors.initials: DD
authors.lastname: Liu
authors.forename: Charles
authors.initials: C
authors.lastname: Lu
authors.forename: You-Hong
authors.initials: YH
authors.lastname: Fan
authors.forename: Waun Ki
authors.initials: WK
authors.lastname: Hong
authors.forename: Li
authors.initials: L
authors.lastname: Mao
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D045744:Cell Line, Tumor; D002764:Cholecystitis / Q000175:diagnosis / Q000235:genetics; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000096:biosynthesis*; D019175:DNA Methylation; D004262:DNA Restriction Enzymes / Q000494:pharmacology; D005260:Female; D005706:Gallbladder Neoplasms / Q000473:pathology; D020868:Gene Silencing; D006801:Humans; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D011401:Promoter Regions, Genetic; D013223:Statistics as Topic; D013447:Sulfites / Q000494:pharmacology; D016896:Treatment Outcome; D025521:Tumor Suppressor Proteins / Q000235:genetics*
chemical_list: D019941:Cyclin-Dependent Kinase Inhibitor p16; C411762:RASSF1 protein, human; D013447:Sulfites; D025521:Tumor Suppressor Proteins; D004262:DNA Restriction Enzymes; C009279:sodium bisulfite